Bright Light as a Personalized Precision Treatment of Mood Disorders
Background: The use of light for its antidepressant action dates back to the beginnings of civilization. Three decades ago, the use of bright-light therapy (BLT) for treating Seasonal Affective Disorder (SAD) was officially proposed. Since then, a growing scientific literature reports its antidepres...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-03-01
|
Series: | Frontiers in Psychiatry |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fpsyt.2019.00085/full |
_version_ | 1818545554809946112 |
---|---|
author | Julia Maruani Julia Maruani Julia Maruani Julia Maruani Pierre Alexis Geoffroy Pierre Alexis Geoffroy Pierre Alexis Geoffroy Pierre Alexis Geoffroy |
author_facet | Julia Maruani Julia Maruani Julia Maruani Julia Maruani Pierre Alexis Geoffroy Pierre Alexis Geoffroy Pierre Alexis Geoffroy Pierre Alexis Geoffroy |
author_sort | Julia Maruani |
collection | DOAJ |
description | Background: The use of light for its antidepressant action dates back to the beginnings of civilization. Three decades ago, the use of bright-light therapy (BLT) for treating Seasonal Affective Disorder (SAD) was officially proposed. Since then, a growing scientific literature reports its antidepressant efficacy in both unipolar and bipolar disorders (BD), with or without seasonal patterns. This review aims to examine the management of BLT as a personalized and precision treatment in SAD, unipolar, and BD.Methods: We conducted a narrative review using Medline and Google Scholar databases up to June 2018.Results: BLT has physiological effects by resynchronizing the biological clock (circadian system), enhancing alertness, increasing sleep pressure (homeostatic system), and acting on serotonin, and other monoaminergic pathways. Effects of BLT on mood depend on several factors such as light intensity, wavelength spectrum, illumination duration, time of the day, and individual circadian rhythms. A growing body of evidence has been generated over the last decade about BLT evolving as an effective depression treatment not only to be used in SAD, but also in non-seasonal depression, with efficiency comparable to fluoxetine, and possibly more robust in patients with BD. The antidepressant action of BLT is fast (within 1-week) and safe, with the need in BD to protect against manic switch with mood stabilizers. Side effects might be nausea, diarrhea, headache, and eye irritation, and are generally mild and rare. This good safety profile may be of particular interest, especially in women during the perinatal period or for the elderly. The management of BLT needs to be clarified across mood disorders and future studies are expected to compare different dose-titration protocols, to validate its use as a maintenance treatment, and also to identify predictive biomarkers of response and tolerability. We propose clinical guidelines for BLT use in SAD, non-seasonal depression, and BD.Conclusions : BLT is an efficient antidepressant strategy in mono- or adjunct-therapy, that should be personalized according the unipolar or bipolar subtype, the presence or absence of seasonal patterns, and also regarding its efficacy and tolerability. |
first_indexed | 2024-12-12T07:41:39Z |
format | Article |
id | doaj.art-c65051030f0145dc8b9ec2328e05b0a0 |
institution | Directory Open Access Journal |
issn | 1664-0640 |
language | English |
last_indexed | 2024-12-12T07:41:39Z |
publishDate | 2019-03-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Psychiatry |
spelling | doaj.art-c65051030f0145dc8b9ec2328e05b0a02022-12-22T00:32:46ZengFrontiers Media S.A.Frontiers in Psychiatry1664-06402019-03-011010.3389/fpsyt.2019.00085412296Bright Light as a Personalized Precision Treatment of Mood DisordersJulia Maruani0Julia Maruani1Julia Maruani2Julia Maruani3Pierre Alexis Geoffroy4Pierre Alexis Geoffroy5Pierre Alexis Geoffroy6Pierre Alexis Geoffroy7Inserm, U1144, Paris, FranceUniversité Paris Descartes, UMR-S 1144, Paris, FranceUniversité Paris Diderot, Sorbonne Paris Cité, UMR-S 1144, Paris, FranceAP-HP, GH Saint-Louis–Lariboisière–F. Widal, Pôle de Psychiatrie et de Médecine Addictologique, Paris, FranceInserm, U1144, Paris, FranceUniversité Paris Descartes, UMR-S 1144, Paris, FranceUniversité Paris Diderot, Sorbonne Paris Cité, UMR-S 1144, Paris, FranceAP-HP, GH Saint-Louis–Lariboisière–F. Widal, Pôle de Psychiatrie et de Médecine Addictologique, Paris, FranceBackground: The use of light for its antidepressant action dates back to the beginnings of civilization. Three decades ago, the use of bright-light therapy (BLT) for treating Seasonal Affective Disorder (SAD) was officially proposed. Since then, a growing scientific literature reports its antidepressant efficacy in both unipolar and bipolar disorders (BD), with or without seasonal patterns. This review aims to examine the management of BLT as a personalized and precision treatment in SAD, unipolar, and BD.Methods: We conducted a narrative review using Medline and Google Scholar databases up to June 2018.Results: BLT has physiological effects by resynchronizing the biological clock (circadian system), enhancing alertness, increasing sleep pressure (homeostatic system), and acting on serotonin, and other monoaminergic pathways. Effects of BLT on mood depend on several factors such as light intensity, wavelength spectrum, illumination duration, time of the day, and individual circadian rhythms. A growing body of evidence has been generated over the last decade about BLT evolving as an effective depression treatment not only to be used in SAD, but also in non-seasonal depression, with efficiency comparable to fluoxetine, and possibly more robust in patients with BD. The antidepressant action of BLT is fast (within 1-week) and safe, with the need in BD to protect against manic switch with mood stabilizers. Side effects might be nausea, diarrhea, headache, and eye irritation, and are generally mild and rare. This good safety profile may be of particular interest, especially in women during the perinatal period or for the elderly. The management of BLT needs to be clarified across mood disorders and future studies are expected to compare different dose-titration protocols, to validate its use as a maintenance treatment, and also to identify predictive biomarkers of response and tolerability. We propose clinical guidelines for BLT use in SAD, non-seasonal depression, and BD.Conclusions : BLT is an efficient antidepressant strategy in mono- or adjunct-therapy, that should be personalized according the unipolar or bipolar subtype, the presence or absence of seasonal patterns, and also regarding its efficacy and tolerability.https://www.frontiersin.org/article/10.3389/fpsyt.2019.00085/fullbright light therapycircadian rhythmssleepseasonal affective disordernon-seasonal depressionbipolar disorder |
spellingShingle | Julia Maruani Julia Maruani Julia Maruani Julia Maruani Pierre Alexis Geoffroy Pierre Alexis Geoffroy Pierre Alexis Geoffroy Pierre Alexis Geoffroy Bright Light as a Personalized Precision Treatment of Mood Disorders Frontiers in Psychiatry bright light therapy circadian rhythms sleep seasonal affective disorder non-seasonal depression bipolar disorder |
title | Bright Light as a Personalized Precision Treatment of Mood Disorders |
title_full | Bright Light as a Personalized Precision Treatment of Mood Disorders |
title_fullStr | Bright Light as a Personalized Precision Treatment of Mood Disorders |
title_full_unstemmed | Bright Light as a Personalized Precision Treatment of Mood Disorders |
title_short | Bright Light as a Personalized Precision Treatment of Mood Disorders |
title_sort | bright light as a personalized precision treatment of mood disorders |
topic | bright light therapy circadian rhythms sleep seasonal affective disorder non-seasonal depression bipolar disorder |
url | https://www.frontiersin.org/article/10.3389/fpsyt.2019.00085/full |
work_keys_str_mv | AT juliamaruani brightlightasapersonalizedprecisiontreatmentofmooddisorders AT juliamaruani brightlightasapersonalizedprecisiontreatmentofmooddisorders AT juliamaruani brightlightasapersonalizedprecisiontreatmentofmooddisorders AT juliamaruani brightlightasapersonalizedprecisiontreatmentofmooddisorders AT pierrealexisgeoffroy brightlightasapersonalizedprecisiontreatmentofmooddisorders AT pierrealexisgeoffroy brightlightasapersonalizedprecisiontreatmentofmooddisorders AT pierrealexisgeoffroy brightlightasapersonalizedprecisiontreatmentofmooddisorders AT pierrealexisgeoffroy brightlightasapersonalizedprecisiontreatmentofmooddisorders |